Eric Welin
About Eric Welin
Eric Welin is a Scientist at Bristol Myers Squibb in San Diego, specializing in Small Molecule Drug Discovery. He has a background in Organic Chemistry with a Ph.D. from Princeton University and has previously worked as an Assistant Professor at The University of Texas at Dallas and a Postdoctoral Fellow at Caltech.
Title
Eric Welin is currently a Scientist at Bristol Myers Squibb in San Diego, California. He joined the company in March 2021, working in the Small Molecule Drug Discovery division.
Previous Academic Positions
Before his current role, Eric Welin was an Assistant Professor at The University of Texas at Dallas from 2019 to 2021 in Richardson, Texas. Prior to that, he completed a four-year postdoctoral fellowship at Caltech from 2015 to 2019 in Pasadena, California.
Graduate and Postdoctoral Research
During his graduate studies at Princeton University, Eric Welin conducted research under the supervision of Professor David MacMillan, focusing on new conceptual developments in Photoredox Catalysis. His doctoral thesis was successfully defended in October 2015. As a postdoctoral fellow at Caltech, he worked on the total synthesis of the anticancer alkaloids Jorunnamycin A and Jorumycin.
Educational Background
Eric Welin earned his Doctor of Philosophy (Ph.D.) in Organic Chemistry from Princeton University, where he studied from 2010 to 2015. Prior to that, he obtained his Bachelor of Science (B.S.) in Chemistry from The Ohio State University, where he studied from 2006 to 2010.